PARP inhibitors – theoretical basis and clinical application
Poly-ADP-ribose polymerases (PARP) are involved in a number of processes that are vital for every living cell. Once activated by the presence of DNA damage they trigger poly-ADP-ribosylation of various proteins which are crucial for DNA repair, preserving of genom integrity, regulation of transcrip...
Main Authors: | Sylwia Dębska, Joanna Kubicka, Rafał Czyżykowski, Maja Habib, Piotr Potemski |
---|---|
Format: | Article |
Language: | English |
Published: |
Index Copernicus International S.A.
2012-05-01
|
Series: | Postępy Higieny i Medycyny Doświadczalnej |
Subjects: | |
Online Access: | http://journals.indexcopernicus.com/fulltxt.php?ICID=999033 |
Similar Items
-
Strategies for the Use of Poly(adenosine diphosphate ribose) Polymerase (PARP) Inhibitors in Cancer Therapy
by: Thomas Helleday, et al.
Published: (2012-12-01) -
Resistance to PARP-inhibitors in Cancer Therapy
by: Alicia eMontoni, et al.
Published: (2013-02-01) -
Poly(ADP-Ribose) Glycohydrolase (PARG) vs. Poly(ADP-Ribose) Polymerase (PARP) – Function in Genome Maintenance and Relevance of Inhibitors for Anti-cancer Therapy
by: Daniel Harrision, et al.
Published: (2020-08-01) -
Current status of poly(ADP-ribose) polymerase inhibitors and future directions
by: Ohmoto A, et al.
Published: (2017-10-01) -
PARP inhibitors in cancer therapy: Magic bullets but moving targets
by: Girish M. Shah, et al.
Published: (2013-11-01)